Short- and long-term outcomes of surgical treatment in patients with intestinal Behcet’s disease

Table 4 Risk factors for recurrence

	Univariate analysis		Multivariate analysis
	HR (95%CI)	P value	HR (95%CI)	P value
Sex	0.358 (0.084-1.518)	0.163	2.372 (0.370-15.186)	0.362
Age at the time of surgery	0.979 (0.923-1.039)	0.487
Use of steroid	1.922 (0.386-9.566)	0.425
Use of colchicine	1.901 (0.232-15.552)	0.549
Use of azathioprine or 6-MP	0.919 (0.219-3.848)	0.908
Use of 5-ASA or sulfasalazine	1.195 (0.241-5.930)	0.828
Use of TNF-α inhibitor	1.485 (0.371-5.945)	0.577
Use of antibiotics	0.279 (0.034-2.267)	0.232
Preoperative CRP level	1.129 (1.031-1.236)	0.009	0.988 (0.868-1.125)	0.855
Preoperative ESR	1.001 (0.978-1.025)	0.925
Preoperative neutrophil	0.973 (0.080-1.172)	0.774
Preoperative lymphocyte	0.898 (0.650-1.240)	0.514
Preoperative procalcitonin	28.659 (0.290-2832.482)	0.152
Preoperative albumin level	0.336 (0.081-1.394)	0.133	0.220 (0.028-1.739)	0.151
Emergency surgery	12.216 (2.669-55.910)	0.001	10.746 (1.486-77.686)	0.019
Open surgery	1.423 (0.340-5.961)	0.629
Postoperative complication	2.051 (0.248-16.962)	0.505

5-ASA: 5-Aminosalicylic acid; 6-MP: 6-Mercaptopurine; TNF: Tumor necrosis factor; CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate; HR: Hazard ratio; CI: Confidence interval.